SEC Filing Summary: India Globalization Capital, Inc.
Business Context and Reporting Period
This Form 8-K was filed by India Globalization Capital, Inc. (not IGC Pharma, Inc.) on July 14, 2011. The filing serves to disclose the company's results of operations for the twelve months ended March 31, 2011, via a press release attached as Exhibit 99.1.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached press release (Exhibit 99.1), which is referenced but not included in the provided text.
Material Changes
The filing does not detail specific material changes versus the prior comparable period. It only confirms the issuance of a press release regarding the results for the twelve months ended March 31, 2011.
Guidance, Outlook, and Risks
The filing contains no management commentary, guidance, outlook, or specific risk factors within the main text. It explicitly states that the information is furnished under Regulation FD and Item 2.02 and is not deemed "filed" for purposes of Section 18 of the Exchange Act, nor is it incorporated by reference into other filings.
Investor Verification Checklist
- Verify the correct registrant name is India Globalization Capital, Inc., not IGC Pharma, Inc.
- Review Exhibit 99.1 (Press Release dated July 14, 2011) for actual financial figures and operational details.
- Confirm the reporting period covers the twelve months ended March 31, 2011.
- Note that this 8-K is a disclosure vehicle and does not contain audited financial statements.